Unfortified nutritional yeast does not contain any added nutrients, while the fortified version has added vitamins
GLP-1 stimulerar insulinfristtning nr blodsockret stiger och hmmar samtidigt glukagon, som annars hjer blodsockret
But all in all, the future looks promising as more oral GLP-1 agonists are in the pipeline
Gou Y, Li X, Li P, Zhang H, Xu T, Wang H, et al

CagriSema is composed of the GLP-1 RA semaglutide and the long-acting insulin analog cagrilintide, and can be administered subcutaneously once a week.117 Beinaglutide Beinaglutide was the first original drug approved for the treatment of obesity in China and the third GLP-1 class reduction drug approved worldwide, and it represents a new treatment option for overweight and obese patients.67,118,119 Beinaglutide, a recombinant human GLP-1 (rhGLP-1) polypeptide, exhibits a remarkable resemblance to human GLP-1(7-36), with nearly 100% homology.120 This innovative compound demonstrates dose-dependent efficacy in regulating glycemic control, suppressing appetite, delaying gastric emptying, and facilitating weight reduction.121 Consequently, beinaglutide holds significant promise for advancing research in the areas of overweight/obesity and nonalcoholic steatohepatitis (NASH).67,122 Beinaglutide is a natural human GLP-1(7-36)-NH2 expressed in Escherichia coli

Instead, they have the ability to flip-flop between glucagon and GLP-1 synthesis, based on which enzyme they are using